Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
Scientific Community
Become a Member | Sign in
Home>News>This Article

Thermo Fisher Showcases New Product Innovations and Best Practices to Optimize Stem Cell Discoveries at ISSCR 2014

Published: Monday, June 23, 2014
Last Updated: Monday, June 23, 2014
Bookmark and Share
Enabling engineering, expansion, differentiation, characterization, cryopreservation and ultra-cold chain to drive drug discovery applications.

The latest advances in innovative technologies designed to streamline the entire stem cell research workflow – from pluripotent cell engineering, culturing, differentiation and characterization to cryopreservation and storage – will be showcased this week during the 12th annual International Society for Stem Cell Research (ISSCR) meeting (Thermo Scientific booth #628, Life Technologies booth #829). 

Thermo Fisher Scientific will host a series of customer and thought leader presentations on topics ranging from the use of Sendai virus reprogramming technology for rapid development of human induced pluripotent stem cells (iPSC) for drug development applications, to industrializing pluripotent stem cells and novel platforms for culturing cells in suspension. The speakers will share new innovations being applied in labs at Harvard University, Cedar-Sinai Medical Center and Saitama Medical University. 

“Access to leading-edge tools that are designed to seamlessly work in combination with each other is critical for our customers to drive new discoveries,” said Chris Armstrong, Ph.D., vice president and general manager, cell biology, for Thermo Fisher. “We’re proud to offer a deep portfolio of technologies that addresses the entire pluripotent stem cell research continuum to enable novel applications in drug discovery and human disease studies.” 

New product innovations at ISSCR this year include: 

• When used in combination, the new Lipofectamine 3000 and Epi5 Episomal iPSC Reprogramming Vector reagents demonstrate robust transfection and development of iPSCs and eliminate the need for electroporation, reduce cytotoxicity for more stable, physiologically relevant iPSCs; 

• The new PSC Cardiomyocyte Differentiation Kit is designed to deliver rapid differentiation of iPSCs to contracting cardiomyocytes in as few as eight days using a simple three-step process; 

• The new Molecular Probes Human Cardiomyocyte Immunocytochemistry and PSC Live Staining Kit is one of nine different characterization kits designed to deliver convenience with all the necessary reagents in a single box to enable superior imaging for fluorescence microscopy-based analysis of live or fixed cells; 

• To elevate stem cell differentiation, the new Thermo Scientific Nunclon Sphera non-adherent cell culture surface optimizes three-dimensional spheroid formation designed to allow researchers to grow cells in suspension with consistency and reproducibility; and 

• Also on display will include Gibco Essential 8 Medium for growing human iPSCs, updated analysis software for the TaqMan hPSC Scorecard Panel (qPCR-based stem cell characterization), Thermo Scientific Nalgene RapidFlow filtration designed to prevent cell culture contamination, Thermo Scientific cryopreservation consumables, and Fisher BioServices ultra cold-chain logistics for cellular therapeutics clinical trials and commercialization. 

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Completes Sale of Cole-Parmer to GTCR
Thermo Fisher Scientific Inc. announced that it has completed the sale of its Cole-Parmer customer channel business to private equity firm GTCR LLC for approximately $480 million in cash.
Wednesday, August 20, 2014
Thermo to Sell Cole-Parmer for $480M
Company has signed a definitive agreement to sell its Cole-Parmer channel business to private equity firm GTCR, LLC for $480 million in cash.
Monday, July 21, 2014
Thermo Completes Sale of Certain Assets to GE
Thermo has completed the sale of its cell culture (sera and media), gene modulation and magnetic beads businesses to GE Healthcare for $1.065 billion.
Monday, March 24, 2014
Thermo Completes Life Tech Acquisition
The completion of the transaction follows the receipt of all required regulatory approvals.
Tuesday, February 04, 2014
Thermo Scientific North Carolina Site Wins IndustryWeek’s Best Plant Award
Center of Excellence honored for exceptional performance, safety and processes.
Wednesday, January 15, 2014
Thermo Receives EC Clearance for Life Tech Acquisition
Thermo Fisher Scientific announced that it has received approval from the European Commission (EC) for its pending acquisition of Life Technologies Corporation.
Tuesday, November 26, 2013
Blood Banks Provide Vital Resource in Global Blood Supply Chain
Thermo Fisher installs 1000th blood banking centrifuge in India.
Monday, November 18, 2013
Thermo Scientific Offering to be Highlighted at ISSCR Stem Cell Research Symposium
The symposium highlights the latest Thermo Scientific tools and technologies available to researchers to advance their understanding of stem cells.
Tuesday, July 07, 2009
Thermo Fisher Scientific Sponsors Shanghai Conference on Stem Cell Research
Thermo Scientific sponsors the 2009 Shanghai Symposium of Stem Cell Research and Regenerative Medicine at the Shanghai Tong Ji University.
Thursday, May 14, 2009
Thermo Fisher Scientific to Highlight new Cell-based Technologies at ASCB 2008
The Company will showcase the latest tools and methods related to key mammalian cell-based research.
Friday, December 12, 2008
Thermo Fisher Scientific Sponsors Industry Symposia on Stem Cell Research
Symposium program will unveil new methods and technologies for stem cell scientists.
Tuesday, June 10, 2008
Thermo Fisher Scientific Launches New Cell Culture Excellence Program
The program is designed to provide essential products and services to address the daily challenges associated with culturing mammalian cells.
Tuesday, June 03, 2008
Scientific News
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
CRI Identifies Emergency Blood-formation Response
Researchers report that when tissue damage occurs, an emergency blood-formation system activates.
New Way to Force Stem Cells to Become Bone Cells
Potential therapies based on this discovery could help people heal bone injuries or set hardware, such as replacement knees and hips.
Dead Bacteria to Kill Colorectal Cancer
Scientists from Nanyang Technological University (NTU Singapore) have successfully used dead bacteria to kill colorectal cancer cells.
Promise of Newborn Stem Cells to Revolutionize Clinical Practice
In this article Shweta Sharma, PhD, discusses the potential of an Umbilical Cord Blood bank as an untapped source of samples for research and clinical trials.
The Life Story of Stem Cells
A model analyses the development of stem cell numbers in the human body.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Advancing Genome Editing of Blood Stem Cells
Genome editing techniques for blood stem cells just got better, thanks to a team of researchers at USC and Sangamo BioSciences.
Molecule Proves Key to Brain Repair After Stroke
Scientists found that a molecule known as growth and differentiation factor 10 (GDF10) plays a key role in repair mechanisms following stroke.
Towards Patient-Specific Drug Screening
A new breakthrough by the 3D stem cell printing team at Heriot-Watt could pave the way to individually tailored drug testing regimes, both reducing the need for animal testing and ensuring that patients receive drugs which are most effective for their individual needs.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos